Showing results (481-490 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|February 9, 2022
Use of Low-Frequency Driver Mutations Detected by Cell-Free Circulating Tumor DNA to Guide Targeted Therapy in Non-Small-Cell Lung Cancer: A Multicenter Case SeriesMiriam T Jacobs, Nisha A Mohindra, Lindsey Shantzer, et al.
JCO Precision Oncology|February 9, 2022
Translating Gene Signatures Into a Pathologic Feature: Tumor Necrosis Predicts Disease Relapse in Operable and Stage I Lung AdenocarcinomaEmily Pei-Ying Lin, Tzu-Hung Hsiao, Jo-Yang Lu, et al.
JCO Precision Oncology|February 9, 2022
Pathogenic Variants in Less Familiar Cancer Susceptibility Genes: What Happens After Genetic Testing?Evan T Hall, Divya Parikh, Jennifer L Caswell-Jin, et al.
JCO Precision Oncology|February 9, 2022
Tumor-Infiltrating Lymphocyte Function Predicts Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal CancerJoseph Cherng Huei Kong, Glen Robert Guerra, Rosemary Magdalena Millen, et al.
JCO Precision Oncology|February 9, 2022
Targeted Therapy for Colorectal Cancers With Non-V600 BRAF Mutations: Perspectives for Precision OncologyMatthew Dankner
JCO Precision Oncology|February 9, 2022
Defining and Targeting Esophagogastric Cancer Genomic Subsets With Patient-Derived XenograftsRyan H Moy, Henry S Walch, Marissa Mattar, et al.
JCO Precision Oncology|February 1, 2022
Validation of HER2 Amplification as a Predictive Biomarker for Anti-Epidermal Growth Factor Receptor Antibody Therapy in Metastatic Colorectal CancerKanwal Raghav, Jonathan M Loree, Jeffrey S Morris, et al.
JCO Precision Oncology|February 1, 2022
Retrospective Survival Analysis of Patients With Resected Pancreatic Ductal Adenocarcinoma and a Germline BRCA or PALB2 MutationShun Yu, Parul Agarwal, Ronac Mamtani, et al.
JCO Precision Oncology|February 1, 2022
High Detection Rate of MYD88 Mutations in Cerebrospinal Fluid From Patients With CNS LymphomasJun Watanabe, Manabu Natsumeda, Masayasu Okada, et al.
JCO Precision Oncology|February 1, 2022
Clinical Utility of Real-Time Targeted Molecular Profiling in the Clinical Management of Ovarian Cancer: The ALLOCATE StudyOlga Kondrashova, Gwo-Yaw Ho, George Au-Yeung, et al.
Pageof 140